This prospective case-control study included 85 patients with lung involvement related to the COVID-19 virus and a group of ...

Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...

Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...

Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...

A new portable and wireless device can detect SARS-CoV-2 and vitamin C, a critical nutrient that helps bolster infection ...

Scientists have developed a simulation method incorporating quantum mechanics to model the electronic structure of nearly 13,000 atoms ... the virus responsible for Covid-19, and the human receptor ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

In the COVID-19 pandemic era, at-home, portable tests were crucial for knowing when to wear a mask or isolate at home. Now, ...

Read here for an analysis of Charles River's (CRL) strong financial performance with high ROE and decreasing liabilities, ...

Although Lonza posted slightly lower sales than analysts had expected in 2024, the Swiss CDMO suggested in its year-end ...

Low vaccination rates may be contributing to the spread of flu, but data suggests the number of cases so far this season is ...

Swiss Biotechnology firm Lonza, which purchased the Genentech facility in Vacaville last year, reported an income of 6.6 billion in Swiss francs (CHF) for the year 2024, which converts to about ...